Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 129,775 shares at $34.00 ($4.5M) on 2021-08-03, disclosed to the SEC on 2021-08-05.
Open-market sale of $4.5M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.99 | 16,225 | $551K | 12.3% |
| 2 | $33.99 | 16,225 | $551K | 12.3% |
| 3 | $34.00 | 27,830 | $946K | 21.0% |
| 4 | $34.00 | 4,170 | $142K | 3.2% |
| 5 | $35.07 | 1,775 | $62K | 1.4% |
| 6 | $35.07 | 1,775 |
| $62K |
| 1.4% |
| 7 | $35.24 | 38,225 | $1.3M | 29.9% |
| 8 | $35.57 | 11,775 | $419K | 9.3% |
| 9 | $35.57 | 11,775 | $419K | 9.3% |
| Total | $34.68 avg | 129,775 | $4.5M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |
| MYGN | SELL | 2021-07-12 | $3.3M | — | Filing → |